Korean biotech firm bought by Parataxis for Bitcoin treasury use
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Why this matters
This bitcoin story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
AI frenzy losing steam leaves bitcoin less volatile than South Korean stocks
Your day-ahead look for July 17, 2026
ConsenSys inadvertently hired North Korean operative who accessed MetaMask’s core code
ConsenSys inadvertently hired a North Korean operative as a developer consultant who accessed MetaMask's core code before being de...
South Korea’s stock market is officially more volatile than BTC
BTC is less volatile than South Korea’s stock market. Since the start of June, South Korea’s benchmark KOSPI has swung an average...
Bitcoin treasury company offers 10% income and still can’t sell nearly half its shares
Swedish Bitcoin treasury firm B Treasury Capital AB expects its new BTC PREF preference share to start trading on the Spotlight St...
Morgan Stanley Launches Spot Bitcoin, Ethereum, and Solana Trading on E*TRADE
Morgan Stanley has completed the rollout of spot crypto trading on E*TRADE, giving eligible clients the ability to buy, sell, and...
Bitmine nears its Ethereum buying limit – Now it needs demand to make the bet pay off
Bitmine plans to slow its Ethereum purchases as its holdings approach 5% of the cryptocurrency’s supply, ending a year of rapid ac...